NYU Winthrop Hospital
Industry
- Academic and Research Institutions
See more in Biomedtracker
Latest on NYU Winthrop Hospital
Pink Sheet
With projections that the global diabetes population will grow from 366 million currently to approximately 552 million by 2030, driven by adult-onset type 2 diabetes, biopharma deal-making in diabetes
In Vivo
Device Transactions Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Late-stage venture rounds tied debt as the most lucrative financing veh
Scrip
IN VITRO DIAGNOSTICS Arch Biopartners Inc. University of Alberta Arch Biopartners gets option to University of Alberta 's IBS diagnostic technology Public Canadian biotech Arch Biopartners In